Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 4.76M
2: EX-21 Subsidiaries List HTML 226K
3: EX-23 Consent of Expert or Counsel HTML 39K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 43K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 43K
6: EX-32 Certification -- §906 - SOA'02 HTML 41K
12: R1 Cover Page HTML 113K
13: R2 Audit Information HTML 44K
14: R3 Consolidated Statement of Income and Comprehensive HTML 152K
Income
15: R4 Consolidated Balance Sheet HTML 186K
16: R5 Consolidated Balance Sheet (Parenthetical) HTML 50K
17: R6 Consolidated Statement of Cash Flows HTML 168K
18: R7 Consolidated Statement of Shareholders Equity HTML 123K
19: R8 Consolidated Statement of Shareholders Equity HTML 46K
(Parenthetical)
20: R9 Nature of Operations and Summary of Significant HTML 111K
Accounting Policies
21: R10 Restructuring and Other Charges HTML 146K
22: R11 Acquisitions (Notes) HTML 110K
23: R12 Property, Plant and Equipment, Net HTML 54K
24: R13 Goodwill and Other Intangible Assets, Net HTML 106K
25: R14 Other Assets And Liabilities, Current and HTML 76K
Noncurrent
26: R15 Debt HTML 122K
27: R16 Tangible Equity Units HTML 47K
28: R17 Leases (Notes) HTML 97K
29: R18 Income Taxes HTML 141K
30: R19 Net Income Per Share HTML 68K
31: R20 Shareholders' Equity HTML 47K
32: R21 Stock Compensation Plans HTML 119K
33: R22 Segment Information HTML 165K
34: R23 Employee Benefits HTML 421K
35: R24 Financial Instruments HTML 159K
36: R25 Accumulated Other Comprehensive Income (Loss) HTML 105K
37: R26 Concentrations of Credit Risk HTML 41K
38: R27 Commitments and Contingencies HTML 72K
39: R28 Redeemable Noncontrolling Interests HTML 57K
40: R29 Business Divestiture HTML 85K
41: R30 Assets Held For Sale HTML 85K
42: R31 Schedule II - Valuation and Qualifying Accounts HTML 76K
and Reserves
43: R32 Nature of Operations and Summary of Significant HTML 155K
Accounting Policies (Policies)
44: R33 Nature of Operations and Summary of Significant HTML 76K
Accounting Policies (Tables)
45: R34 Restructuring and Other Charges (Tables) HTML 141K
46: R35 Acquisitions (Tables) HTML 96K
47: R36 Property, Plant and Equipment, Net (Tables) HTML 52K
48: R37 Goodwill and Other Intangible Assets, Net (Tables) HTML 108K
49: R38 Other Assets And Liabilities, Current and HTML 80K
Noncurrent (Tables)
50: R39 Debt (Tables) HTML 98K
51: R40 Leases (Tables) HTML 99K
52: R41 Income Taxes (Tables) HTML 139K
53: R42 Net Income Per Share (Tables) HTML 63K
54: R43 Stock Compensation Plans (Tables) HTML 127K
55: R44 Segment Information (Tables) HTML 159K
56: R45 Employee Benefits (Tables) HTML 432K
57: R46 Financial Instruments (Tables) HTML 157K
58: R47 Accumulated Other Comprehensive Income (Loss) HTML 108K
(Tables)
59: R48 Redeemable Noncontrolling Interests (Tables) HTML 56K
60: R49 Discontinued Operations and Disposal Groups HTML 81K
(Tables)
61: R50 Assets Held For Sale (Tables) HTML 81K
62: R51 Nature of Operations and Summary of Significant HTML 163K
Accounting Policies - Additional Information
(Detail)
63: R52 Nature of Operations and Summary of Significant HTML 49K
Accounting Policies - Schedule of Inventory
(Detail)
64: R53 Restructuring and Other Charges - Additional HTML 110K
Information (Details)
65: R54 Restructuring and Other Charges - Movements in HTML 92K
Restructuring and Related Accruals (Detail)
66: R55 Acquisitions - Health Wright Products (Details) HTML 63K
67: R56 Acquisitions - Nutrition & Biosciences, Inc HTML 205K
(Details)
68: R57 Property, Plant and Equipment, Net - Schedule of HTML 66K
Property, Plant and Equipment (Detail)
69: R58 Goodwill and Other Intangible Assets, Net - HTML 64K
Narrative (Details)
70: R59 Goodwill and Other Intangible Assets, Net - HTML 78K
Goodwill Rollforward (Details)
71: R60 Goodwill and Other Intangible Assets, Net - HTML 56K
Trademark and Other Intangible Assets (Detail)
72: R61 Goodwill and Other Intangible Assets, Net - HTML 54K
Amortization Expense (Detail)
73: R62 Other Assets And Liabilities, Current and HTML 69K
Noncurrent - Schedule of Other Assets (Detail)
74: R63 Other Assets And Liabilities, Current and HTML 76K
Noncurrent - Schedule of Other Current Liabilities
(Details)
75: R64 Debt - Components of Debt (Detail) HTML 394K
76: R65 Debt - Additional Information (Detail) HTML 422K
77: R66 Debt - Schedule of Debt Maturities (Details) HTML 60K
78: R67 Tangible Equity Units (Details) HTML 44K
79: R68 Tangible Equity Units (Allocation of TEU) HTML 40K
(Details)
80: R69 Tangible Equity Units Tangible Equity - Settlement HTML 43K
of Shares (Details)
81: R70 Leases (Details) HTML 55K
82: R71 Leases - Schedule of Lease Expense (Details) HTML 43K
83: R72 Leases - Cash Flow (Details) HTML 48K
84: R73 Leases - Balance Sheet (Details) HTML 62K
85: R74 Leases - Weighted Average (Details) HTML 48K
86: R75 Leases - Schedule of Lease Maturities (Details) HTML 95K
87: R76 Leases - Additional Information (Details) HTML 53K
88: R77 Income Taxes - Schedule of Earnings before Income HTML 49K
Taxes (Detail)
89: R78 Income Taxes - Schedule of Income Tax Provision HTML 68K
(Detail)
90: R79 Income Taxes - Reconciliation of Effective Income HTML 78K
Tax Rate (Details)
91: R80 Income Taxes - Schedule of Reconciliation between HTML 52K
U.S. Federal Statutory Income Tax Rate to Actual
Effective Tax Rate (Detail)
92: R81 Income Taxes - Additional Information (Detail) HTML 100K
93: R82 Income Taxes - Schedule of Deferred Tax Assets and HTML 73K
Liabilities (Detail)
94: R83 Income Taxes - Reconciliation of Beginning and HTML 65K
Ending Amount of Unrecognized Tax Benefits
(Detail)
95: R84 Revenue Recognition - Disaggregation of Revenue HTML 53K
(Details)
96: R85 Net Income Per Share - Reconciliation of Shares HTML 78K
Used in Computation of Basic and Diluted Net
Income Per Share (Detail)
97: R86 Net Income Per Share - Additional Information HTML 61K
(Detail)
98: R87 Net Income Per Share - TEU (Details) HTML 50K
99: R88 Shareholders' Equity - Additional Information HTML 54K
(Detail)
100: R89 Stock Compensation Plans - Additional Information HTML 98K
(Detail)
101: R90 Stock Compensation Plans - Stock-Based HTML 50K
Compensation Expense Included in Consolidated
Statement of Income and Comprehensive Income
(Detail)
102: R91 Stock Compensation Plans - SSAR's and Stock Option HTML 55K
- Additional Information (Detail)
103: R92 Stock Compensation Plans - SSAR's and Stock Option HTML 71K
Activity (Detail)
104: R93 Stock Compensation Plans - SSAR's and Stock Option HTML 61K
Outstanding (Detail)
105: R94 Stock Compensation Plans - SSAR's and Stock Option HTML 51K
Exercisable (Detail)
106: R95 Stock Compensation Plans - Restricted Stock Units HTML 55K
Plan - Additional Information (Detail)
107: R96 Stock Compensation Plans - RSU, PRS and Cash RSU HTML 90K
Activity (Detail)
108: R97 Stock Compensation Plans - Purchased Restricted HTML 58K
Stock Plan - Additional Information (Detail)
109: R98 Stock Compensation Plans - Liability Awards - HTML 54K
Additional Information (Detail)
110: R99 Segment Information - Additional Information HTML 68K
(Detail)
111: R100 Segment Information - Reportable Segment HTML 127K
Information (Detail)
112: R101 Segment Information - Capital Expenditure and HTML 55K
Depreciation and Amortization by Segment (Detail)
113: R102 Segment Information - Net Sales by Geographic Area HTML 58K
(Detail)
114: R103 Segment Information Segment Information - Schedule HTML 57K
of Long Lived Assets (Details)
115: R104 Employee Benefits - Additional Information HTML 105K
(Detail)
116: R105 Employee Benefits - Plan Assets and Benefit HTML 92K
Obligations of Defined Benefit Pension Plans
(Detail)
117: R106 Employee Benefits - Components of Net Periodic HTML 64K
Benefit Cost and Changes in Plan Assets and
Benefit Obligations Recognized in OCI (Detail)
118: R107 Employee Benefits - Weighted-Average Actuarial HTML 52K
Assumption Used to Determine Expense (Detail)
119: R108 Employee Benefits - Changes in Postretirement HTML 123K
Benefit Obligation and Plan Assets (Detail)
120: R109 Employee Benefits - Amounts Recognized in Balance HTML 58K
Sheet (Detail)
121: R110 Employee Benefits - Amounts Recognized in HTML 55K
Accumulated Other Comprehensive Income (Detail)
122: R111 Employee Benefits - Accumulated Benefit Obligation HTML 61K
(Detail)
123: R112 Employee Benefits - Estimated Future Benefit HTML 64K
Payments (Detail)
124: R113 Employee Benefits - Percentage of Assets Invested HTML 60K
(Detail)
125: R114 Employee Benefits - Fair Value Hierarchy of Plan HTML 195K
Assets (Detail)
126: R115 Employee Benefits - Reconciliation of Level 3 HTML 64K
Non-U.S. Plan Assets Held (Detail)
127: R116 Employee Benefits - Weighted Average Assumptions HTML 49K
Used to Determine Postretirement Benefit Expense
and Obligation (Detail)
128: R117 Employee Benefits - Sensitivity of Disclosures to HTML 55K
Changes in Selected Assumptions (Detail)
129: R118 Financial Instruments - Carrying Amount and HTML 118K
Estimated Fair Value of Financial Instruments
(Detail)
130: R119 Financial Instruments - Derivative Instruments HTML 47K
Notional Amount Outstanding (Detail)
131: R120 Financial Instruments - Derivative Instruments HTML 64K
Measured at Fair Value (Detail)
132: R121 Financial Instruments - Derivative Instruments HTML 45K
Which Were Not Designated as Hedging Instruments
(Detail)
133: R122 Financial Instruments - Derivative Instruments HTML 82K
Designated as Cash Flow and Net Investment Hedging
Instruments (Detail)
134: R123 Financial Instruments - Additional Information HTML 95K
(Detail)
135: R124 Accumulated Other Comprehensive Income (Loss) - HTML 67K
Schedule of Changes in Accumulated Other
Comprehensive Income (Loss) (Detail)
136: R125 Accumulated Other Comprehensive Income (Loss) - HTML 77K
Reclassifications of Accumulated Other
Comprehensive Income to Consolidated Statement of
Comprehensive Income (Detail)
137: R126 Concentrations Of Credit Risk - Additional HTML 48K
Information (Detail)
138: R127 Commitments and Contingencies - Additional HTML 135K
Information (Detail)
139: R128 Redeemable Noncontrolling Interests (Details) HTML 65K
140: R129 Business Divestiture (Details) HTML 98K
141: R130 Assets Held For Sale (Details) HTML 90K
142: R131 Schedule II - Valuation and Qualifying Accounts HTML 59K
and Reserves (Detail)
145: XML IDEA XML File -- Filing Summary XML 281K
143: XML XBRL Instance -- iff-20221231_htm XML 7.13M
144: EXCEL IDEA Workbook of Financial Reports XLSX 415K
8: EX-101.CAL XBRL Calculations -- iff-20221231_cal XML 440K
9: EX-101.DEF XBRL Definitions -- iff-20221231_def XML 2.47M
10: EX-101.LAB XBRL Labels -- iff-20221231_lab XML 4.29M
11: EX-101.PRE XBRL Presentations -- iff-20221231_pre XML 3.14M
7: EX-101.SCH XBRL Schema -- iff-20221231 XSD 444K
146: JSON XBRL Instance as JSON Data -- MetaLinks 1,012± 1.62M
147: ZIP XBRL Zipped Folder -- 0000051253-23-000009-xbrl Zip 1.30M
1.I have reviewed this Annual Report on Form 10-K of International Flavors & Fragrances Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,
not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant
deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
